Mass Hysteria Ent (MHYS) 0.0001 $MHYS Mass Hysteria

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mass Hysteria Ent (MHYS) 0.0001 $MHYS

Mass Hysteria Entertainment Acquires Thriller From "Jeepers Creepers"
ACCESSWIRE - Wed Mar 25, 4:33AM CDT
Director To Sell at the Cannes Film Festival

Daniel Grodnik's Mass Hysteria Entertainment Sets Director for New Action Movie
ACCESSWIRE - Thu Feb 12, 5:32AM CST
HOLLYWOOD, CA / ACCESSWIRE / February 12, 2015 / Mass Hysteria Entertainment Company, Inc. (OTC: MHYS) announced today it has acquired the rights to the motion picture screenplay, End of a Gun, written by former ATF Agent, Chuck Hustmyre, whose most recent film, House of the Rising Sun, starred Guardian of the Galaxy's Dave Bautista.

Mass Hysteria Entertainment to Produce Punjab Tiger
ACCESSWIRE - Thu Feb 05, 6:30AM CST
HOLLYWOOD, CA / ACCESSWIRE / February 5, 2015 / Mass Hysteria Entertainment Company, Inc. (OTC: MHYS) announced today it has agreed to come aboard to co-produce the independent film, PunJab Tiger, based on the true story of an Indian man, to be played by Prem Singh, who is banned from the sport of boxing because he wouldn't compromise his religious convictions and stood up for his rights. Prem Singh is also the co-writer of the screenplay along with his partner, Michael Pugliese, who will also play an important role in the movie. The project will be co-produced with Aloe Entertainment. "Punjab Tiger meets our current mandate to produce films that we believe will attract important stars and has award winning potential. Mary Aloe and I are working on a number of new projects together and I am delighted she asked me to join her as a producer on Punjab," said Daniel Grodnik, CEO of Mass Hysteria Entertainment.

Mass Hysteria Entertainment Company Signs Development Deal With Watson & Holmes
ACCESSWIRE - Wed Jan 28, 5:45AM CST
HOLLYWOOD, CA / ACCESSWIRE / January 28, 2015 / Mass Hysteria Entertainment Company, Inc. (OTC Pink: MHYS) (PINKSHEETS: MHYS), announced today it has signed a screenplay development deal with Watson & Holmes Story Labs. Watson & Holmes is the brainchild of businessman C.W. Mahne and screenwriter D. Michael Robinson. The company focuses on the development of broad ranging content, including literary, film and television. Robinson explained, "With Story Labs, we've funded a kind of creative greenhouse where we can grow content for film and television."

Mass Hysteria Entertainment Company Signs Development Deal With Watson and Holmes
eTeligis - Wed Jan 28, 5:30AM CST
HOLLYWOOD, CA, United States, via ETELIGIS INC., 01/28/2015 - - Mass Hysteria Entertainment Company, Inc. (OTC Pink: MHYS) (PINKSHEETS: MHYS), announced today it has signed a screenplay development deal with Watson & Holmes Story Labs. Watson & Holmes is the brainchild of businessman C.W. Mahne and screenwriter D. Michael Robinson. The company focuses on the development of broad ranging content, including literary, film and television. Robinson explained, "With Story Labs, we've funded a kind of creative greenhouse where we can grow content for film and television."

Mass Hysteria Entertainment Wraps First Co-Financed Feature "Daughter of God" Starring Keanu Reeves
ACCESSWIRE - Thu Dec 11, 4:53AM CST
Hollywood, CA /ACCESSWIRE / December 11, 2014 / Daniel Grodnik's Mass Hysteria Entertainment Company, Inc. (OTC Pink: MHYS) (PINKSHEETS: MHYS), announced today the completion of production in New York on Gee Malik Linton's dramatic thriller "Daughter of God", starring Keanu Reeves and Ana de Armas with financiers Seth and Curt Kramer under the production banner of Remark Pictures. The new self-financed production entity is already looking ahead with three new co-financing opportunities under serious consideration for 2015. Two of the projects are late stage packages with directors, stars and select international sales already completed.

Prosecutors in NYC indict 8 in stock fraud case
By JAKE PEARSON - AP - Thu Sep 11, 5:49PM CDT
NEW YORK (AP) — Four of eight people charged in a penny stock "pump and dump" scheme that defrauded $290 million from thousands of investors were arraigned on Thursday following a two-year investigation.

Keanu Reeves and Ana De Armas to Star in Gee Malik Linton's Dramatic Thriller "Daughter Of God"
ACCESSWIRE - Tue Sep 09, 4:51AM CDT
HOLLYWOOD, CA / ACCESSWIRE / September 9, 2014 / Mass Hysteria Entertainment Company, Inc. (OTC:MHYS)(PINKSHEETS:MHYS) Keanu Reeves and Ana de Armas will star in Gee Malik Linton's dramatic thriller DAUGHTER OF GOD, it was announced today by Fortitude International. Linton wrote the script and is directing the project, which is scheduled to commence principal photography in November. Fortitude represents international rights and company principal Nadine de Barros has kicked-off sales at the 2014 Toronto International Film Festival.

Keanu Reeves and Ana De Armas to Star in Gee Malik Lintons Dramatic Thriller Daughter Of God
eTeligis - Tue Sep 09, 4:31AM CDT
HOLLYWOOD, CA, United States, via ETELIGIS INC., 09/09/2014 - - Mass Hysteria Entertainment Company, Inc. (OTC:MHYS) (PINKSHEETS:MHYS) Keanu Reeves and Ana de Armas will star in Gee Malik Linton's dramatic thriller DAUGHTER OF GOD, it was announced today by Fortitude International. Linton wrote the script and is directing the project, which is scheduled to commence principal photography in November. Fortitude represents international rights and company principal Nadine de Barros has kicked-off sales at the 2014 Toronto International Film Festival.

Mass Hysteria Entertainment Company is Looking for Dynamic Movies to Finance
ACCESSWIRE - Thu Aug 14, 5:27AM CDT
HOLLYWOOD, CA / ACCESSWIRE / August 14, 2014 / Mass Hysteria Entertainment Company, Inc. (OTC Pink: MHYS) (PINKSHEETS: MHYS), under the new brand name of Remark Pictures is actively looking for theatrical motion pictures that are in need of funding. The Company is currently analyzing scripts and packages with recognizable stars and directors in hopes of entering into negotiations shortly to proceed on a couple of projects for the fall. "Remark's mandate is to build a portfolio of dynamic films," said Daniel Grodnik the Company's CEO. "We're interested in film properties at all stages of development and under select circumstances would consider putting up development money. Our search is focused primarily on dramas and thrillers with established marquee names."

Mass Hysteria Entertainment Changes Company Direction and Intends to Rebrand Under the Name Remark Pictures
ACCESSWIRE - Mon Aug 04, 8:56AM CDT
HOLLYWOOD, CA / ACCESSWIRE / August 4, 2014 / Mass Hysteria Entertainment Company, Inc. (OTCQB: MHYS) has changed its' mandate to become a full fledged financier and producer of theatrical movies under the new brand name of REMARK PICTURES. The Company is proceeding with the name change and will seek a new symbol from FINRA. "This change in direction moves the Company from development stage to operational," said the Company's CEO, Daniel Grodnik. "The independent film business today is red hot for quality content and I believe our credentials, experience and access in Hollywood uniquely position us to become a leader in the space."

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Supply Crunch from CATL's Decision Triggers Lithium Market Rally

Updated Category News Views 98

CATL's Halt of Lithium Production Shakes Up the Market Recently, CATL grabbed attention by stopping operations at a significant lithium production site. This move, officially confirmed by the company, was a response to shifting conditions in the lithium carbonate market, particularly in Yichun. Effects on Lithium Supply and Pricing As a result of this suspension, China's...

Continue Reading
Cohen & Steers Fund Distribution Insights and Performance Update

Updated Category News Views 216

Understanding Distribution Sources for Cohen & Steers Fund Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) has provided vital information regarding the sources of its distributions. The fund aims to keep its shareholders well-informed about the dividends expected in the upcoming payment period. The Managed Distribution Policy Explained The fund's investment...

Continue Reading
SiteOne Landscape Supply: Insider Sell Raises Questions

Updated Category News Views 171

February 17 was a noteworthy date for SiteOne Landscape Supply (NYSE:SITE) as insider Eric Elema, the company's EVP, made waves with a substantial stock sale of 1,765 shares amounting to $278,887. Insider selling can often send mixed signals to the market; while it might raise eyebrows about internal confidence, it doesn’t always equate to a bearish sentiment on the...

Continue Reading
ArcBest Outlines Growth Strategies and Financial Goals for 2028

Updated Category News Views 244

ArcBest's Vision for Future Growth ArcBest is committed to a future of logistics excellence, emphasizing a strategy built on growth, efficiency, and innovation. At the recent investor day, the leadership team provided a roadmap for the company's journey towards ambitious financial targets set for 2028. Integrating Technology for Superior Logistics Solutions As a leading...

Continue Reading
Barolo and Barbaresco Academy Roadshow: A Wine Journey

Updated Category News Views 131

Barolo and Barbaresco Academy Roadshow Celebrates Success The Academy Roadshow recently concluded with a series of sold-out seminars across multiple cities in the Southwest, showcasing an increasing interest in Barolo and Barbaresco wines. This event gathered wine professionals and enthusiasts eager to deepen their understanding of these exceptional wines. Highlights of...

Continue Reading